These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Opto-chemogenetics with luminopsins: A novel avenue for targeted control of neuronal activity. Berglund K; Gross RE J Neurosci Res; 2020 Mar; 98(3):407-409. PubMed ID: 31157461 [No Abstract] [Full Text] [Related]
4. Overview on Research and Clinical Applications of Optogenetics. Towne C; Thompson KR Curr Protoc Pharmacol; 2016 Dec; 75():11.19.1-11.19.21. PubMed ID: 27960028 [TBL] [Abstract][Full Text] [Related]
5. Molecular tools and approaches for optogenetics. Mei Y; Zhang F Biol Psychiatry; 2012 Jun; 71(12):1033-8. PubMed ID: 22480664 [TBL] [Abstract][Full Text] [Related]
6. Optogenetics and deep brain stimulation neurotechnologies. Kondabolu K; Kowalski MM; Roberts EA; Han X Handb Exp Pharmacol; 2015; 228():441-50. PubMed ID: 25977092 [TBL] [Abstract][Full Text] [Related]
7. Optogenetics in psychiatric diseases. TouriƱo C; Eban-Rothschild A; de Lecea L Curr Opin Neurobiol; 2013 Jun; 23(3):430-5. PubMed ID: 23642859 [TBL] [Abstract][Full Text] [Related]
8. Neural circuit reprogramming: a new paradigm for treating neuropsychiatric disease? Tye KM Neuron; 2014 Sep; 83(6):1259-61. PubMed ID: 25233309 [TBL] [Abstract][Full Text] [Related]
9. Efforts to control monkey brains get a boost. Servick K Science; 2020 Oct; 370(6516):516-517. PubMed ID: 33122366 [No Abstract] [Full Text] [Related]
12. Optogenetics: opsins and optical interfaces in neuroscience. Adamantidis AR; Zhang F; de Lecea L; Deisseroth K Cold Spring Harb Protoc; 2014 Aug; 2014(8):815-22. PubMed ID: 25086025 [TBL] [Abstract][Full Text] [Related]
13. Optogenetic approaches for investigating neural pathways implicated in schizophrenia and related disorders. Cho KK; Sohal VS Hum Mol Genet; 2014 Sep; 23(R1):R64-8. PubMed ID: 24824218 [TBL] [Abstract][Full Text] [Related]
14. Opsins for vision restoration. Simon CJ; Sahel JA; Duebel J; Herlitze S; Dalkara D Biochem Biophys Res Commun; 2020 Jun; 527(2):325-330. PubMed ID: 31982136 [TBL] [Abstract][Full Text] [Related]
15. A bright future? Optogenetics in the periphery for pain research and therapy. Mickle AD; Gereau RW Pain; 2018 Sep; 159 Suppl 1(Suppl 1):S65-S73. PubMed ID: 30113949 [No Abstract] [Full Text] [Related]
16. Transparent intracortical microprobe array for simultaneous spatiotemporal optical stimulation and multichannel electrical recording. Lee J; Ozden I; Song YK; Nurmikko AV Nat Methods; 2015 Dec; 12(12):1157-62. PubMed ID: 26457862 [TBL] [Abstract][Full Text] [Related]
17. Combined Optogenetic and Chemogenetic Control of Neurons. Berglund K; Tung JK; Higashikubo B; Gross RE; Moore CI; Hochgeschwender U Methods Mol Biol; 2016; 1408():207-25. PubMed ID: 26965125 [TBL] [Abstract][Full Text] [Related]
18. Optogenetics and Chemogenetics. Vlasov K; Van Dort CJ; Solt K Methods Enzymol; 2018; 603():181-196. PubMed ID: 29673525 [TBL] [Abstract][Full Text] [Related]
19. A new technique for controlling the brain: optogenetics and its potential for use in research and the clinic. LaLumiere RT Brain Stimul; 2011 Jan; 4(1):1-6. PubMed ID: 21255749 [TBL] [Abstract][Full Text] [Related]
20. An optogenetic approach in epilepsy. Kokaia M; Andersson M; Ledri M Neuropharmacology; 2013 Jun; 69():89-95. PubMed ID: 22698957 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]